Key statistics
On Friday, Edwards Lifesciences Corp (EW:NYQ) closed at 78.05, -18.06% below its 52-week high of 95.25, set on Jul 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 78.26 |
---|---|
High | 78.39 |
Low | 77.05 |
Bid | 77.00 |
Offer | 78.44 |
Previous close | 78.80 |
Average volume | 3.28m |
---|---|
Shares outstanding | 586.60m |
Free float | 584.39m |
P/E (TTM) | 32.20 |
Market cap | 45.78bn USD |
EPS (TTM) | 2.42 USD |
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
More ▼
- Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes
- Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference
- Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis
- Edwards Lifesciences Reports First Quarter Results
- Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue
- Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025
- Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
More ▼